StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Last viewed:
CVKD
Prices are updated after-hours
Sector
Industry
Name
Cadrenal Therapeutics, Inc.
1
Symbol
Aacaf
1
Aacay
1
Aacg
1
Aaci
1
Aact
1
Aadi
1
Aagh
1
Aagr
1
Aal
1
Aame
1
Aaoi
1
Aaon
1
Aapl
1
Aaql
1
Aasp
1
Aatc
1
Aatp
1
Aawh
1
Aaww
1
Abbny
1
Abcb
1
Abce
1
Abcff
1
Abcl
1
Abcm
1
Abcp
1
Abczf
1
Abeo
1
Abgi
1
Abilf
1
Abio
1
Abit
1
Ablv
1
Ablzf
1
Abmc
1
Abmd
1
Abmt
1
Abnaf
1
Abnb
1
Abos
1
Abqq
1
Absi
1
Abst
1
Abti
1
Abtx
1
Abus
1
Abvc
1
Abvn
1
Abvx
1
Abwn
1
Abxxf
1
Acab
1
Acac
1
Acad
1
Acah
1
Acan
1
Acaq
1
Acax
1
Acba
1
Acbm
1
Venue
Nasdaq
1
Ipo Year
N::a
1
Country
Na
1
Sec Forms
10-k
1
10-q
1
3
1
3::a
1
4
1
424b3
1
424b4
1
8-a12b
1
8-k
1
8-k::a
1
Ars
1
Cert
1
D
1
Def 14a
1
Effect
1
S-1
1
S-1::a
1
S-3
1
S-8
1
Sc 13g
1
Sec Forms Date
2024 - 04 - 10
1
2024 - 04 - 09
1
2024 - 04 - 03
1
2024 - 03 - 21
1
2024 - 03 - 12
1
2024 - 03 - 11
1
2024 - 02 - 15
1
2024 - 02 - 13
1
2024 - 01 - 20
1
2023 - 11 - 09
1
2023 - 10 - 06
1
2023 - 09 - 06
1
2023 - 09 - 05
1
2023 - 08 - 28
1
2023 - 08 - 18
1
2023 - 08 - 16
1
2023 - 08 - 10
1
2023 - 08 - 01
1
2023 - 07 - 31
1
2023 - 07 - 24
1
2023 - 07 - 14
1
2023 - 05 - 10
1
2023 - 03 - 31
1
2023 - 03 - 30
1
2023 - 03 - 27
1
2023 - 03 - 16
1
2023 - 02 - 13
1
2023 - 01 - 25
1
2023 - 01 - 24
1
2023 - 01 - 23
1
2023 - 01 - 20
1
2023 - 01 - 17
1
2022 - 12 - 28
1
2022 - 12 - 08
1
2022 - 12 - 06
1
2022 - 10 - 17
1
News In 15d
2
1
News In 30d
2
1
Created At
2022 - 10 - 02
1
CVKD
Nasdaq
Cadrenal Therapeutics, Inc.
CVKD
|
$0.4187
-0.71%
-0.72%
160K
|
(
0.0%
1d)
(
-31.6%
1m)
(
-76.2%
1y)
(
0.0%
2d)
(
0.0%
3d)
(
-5.5%
7d)
(
21.8%
volume)
Earnings Calendar:
Market Cap: $ 6,702,746
Sec Filling
|
Patents
| n/a employees
CVKD
add to watch list
Paper trade
email alert is off
Press-releases
Cadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024
Published:
2024-04-11
(Crawled : 21:00)
- prnewswire.com
CVKD
|
$0.4187
-0.71%
-0.72%
160K
|
|
-10.57%
|
O:
-5.3%
H:
8.26%
C:
-0.05%
conference
therapeutics
growth
Zura Bio Announces Robert Lisicki as CEO and Director
Published:
2024-04-08
(Crawled : 11:00)
- biospace.com/
CVKD
|
$0.4187
-0.71%
-0.72%
160K
|
|
-26.85%
|
O:
6.72%
H:
0.0%
C:
-10.34%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-5.09%
|
O:
-0.48%
H:
0.0%
C:
0.0%
ceo
Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Update
Published:
2024-03-11
(Crawled : 17:00)
- biospace.com/
CVKD
|
$0.4187
-0.71%
-0.72%
160K
|
|
-41.77%
|
O:
-4.12%
H:
5.84%
C:
1.37%
update
therapeutics
Cadrenal Therapeutics Appoints Jeff Cole as Chief Operating Officer in Advance of Tecarfarin Phase 3 Pivotal Trial
Published:
2024-02-08
(Crawled : 22:00)
- biospace.com/
CVKD
|
$0.4187
-0.71%
-0.72%
160K
|
|
-65.5%
|
O:
-14.15%
H:
2.05%
C:
-6.2%
trial
therapeutics
Cadrenal Therapeutics Highlights Publication of Peer-Reviewed Article Supporting Need for New Anticoagulation Therapy for Patients with Certain Medical Conditions
Published:
2024-01-31
(Crawled : 15:30)
- biospace.com/
CVKD
|
$0.4187
-0.71%
-0.72%
160K
|
|
-76.79%
|
O:
-1.79%
H:
12.12%
C:
10.3%
publication
medical
therapeutics
therapy
Cadrenal Therapeutics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
Published:
2024-01-24
(Crawled : 14:30)
- biospace.com/
CVKD
|
$0.4187
-0.71%
-0.72%
160K
|
|
-62.15%
|
O:
1.94%
H:
16.98%
C:
16.98%
conference
therapeutics
Cadrenal Therapeutics Engages The Sage Group to Advance Tecarfarin's Late-Stage Development and Commercialization
Published:
2023-12-12
(Crawled : 21:00)
- biospace.com/
CVKD
|
$0.4187
-0.71%
-0.72%
160K
|
|
-22.18%
|
O:
8.38%
H:
3.13%
C:
-6.96%
PPRUF
|
News
|
$361.9
37.56%
4.3K
|
Consumer Non-Durables
|
-16.9%
|
O:
3.3%
H:
0.0%
C:
-2.63%
PPRUY
|
News
|
$36.03
-0.11%
330K
|
Manufacturing
|
-18.41%
|
O:
0.88%
H:
0.0%
C:
-0.52%
group
commercialization
therapeutics
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2023 Investor Conference
Published:
2023-10-09
(Crawled : 23:00)
- biospace.com/
CVKD
|
$0.4187
-0.71%
-0.72%
160K
|
|
-38.36%
|
O:
2.78%
H:
1.52%
C:
-4.63%
conference
therapeutics
Cadrenal Therapeutics Highlights Additional Need for a New Vitamin K Antagonist (Tecarfarin) Following Updates from the Recent European Society of Cardiology Congress
Published:
2023-09-05
(Crawled : 15:00)
- biospace.com/
CVKD
|
$0.4187
-0.71%
-0.72%
160K
|
|
-56.24%
|
O:
7.74%
H:
1.77%
C:
-9.38%
congress
therapeutics
cardiology
Cadrenal Therapeutics Expands Evaluation of Tecarfarin for Patients with Antiphospholipid Syndrome (APS)
Published:
2023-08-30
(Crawled : 14:00)
- biospace.com/
CVKD
|
$0.4187
-0.71%
-0.72%
160K
|
|
-45.08%
|
O:
5.49%
H:
0.0%
C:
-2.54%
therapeutics
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001213900-24-031923
4
2024-04-10
2024-04-10
Sell
G
50000
3275000
Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
66%
34%
Top 10 Gainers
AGBA
|
$1.02
155.0%
60.78%
120M
|
Finance
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
$0.92
84.0%
45.65%
900K
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
ZCMD
|
$2.44
78.1%
43.85%
330K
|
Commercial Services
XPON
|
$3.1
60.62%
37.74%
16M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Last 48 Hours Insiders Buying
AXR
P
2400
|
$22.17
2.69%
0.0%
5.5K
|
Finance
|
21:00
FAST
P
3350
|
$67.5
-1.43%
-1.45%
3.6M
|
Distribution Services
|
20:00
QCRH
|
$55.405
1.33%
1.31%
54K
|
Finance
|
18:01
RVP
P
15363
|
$1.05
0.96%
0.0%
120K
|
Health Technology
|
18:00
VUZI
|
$1.26
3.28%
3.17%
1M
|
Electronic Technology
|
18:00
TPL
P
3
|
$582.4
-0.44%
0.0%
63K
|
Miscellaneous
|
15:00
RELL
|
$10.15
2.94%
2.86%
94K
|
Electronic Technology
|
13:30
IZEA
|
$2.65
4.74%
4.53%
31K
|
Technology Services
|
00:00
RKT
P
383
|
$11.53
1.32%
0.0%
1.6M
|
Finance
|
22:30
CTRN
P
18090
|
$22.28
-0.4%
-0.4%
55K
|
Retail Trade
|
22:00
BRN
P
10650
|
$2.8
0.36%
-0.36%
54K
|
Energy Minerals
|
21:00
NEOG
P
10000
|
$11.94
-1.65%
-1.68%
2.9M
|
Health Technology
|
16:30
RMCF
|
$3.61
2.27%
2.22%
18K
|
Consumer Non-Durables
|
20:10
12 months watchlist earnings calendar